Gastroenterology 136, 20032014
Decotiis Explains Overcoming barriers Oral delivery of GLP-1 therapies is advancing through two complementary strategies that aim to overcome low gastric stability and poor epithelial uptake
Epithalon Side Effects Epithalon has a favorable safety profile with no major side effects having been associated with long-term administration of the peptide
Also, doses of 1000 mg taken two or three times daily seems to work better than doses of 500 mg three times daily
Additionally, non-motor symptoms include gastrointestinal (GI) disorders such as constipation, dysphagia, and delayed gastric emptying [3, 4]
[12] [13] A comprehensive 2017 meta-analysis published in Diabetes Care examined data from over 60,000 patients and found no statistically significant increased risk of pancreatitis with GLP-1 agonists versus comparators